344285-85-4

Upstream product

• 105-36-2 ethyl bromoacetate 
• 344285-84-3 4-amino-2-chlorophenethyl alcohol 
• 69395-15-9 2-(2-chloro-4-nitro-phenyl)-ethanol 

Downstream Products

• 227467-66-5 ethyl N-[4-(2-bromoethyl)-3-chlorophenyl]aminoacetate 
• 227467-82-5 ethyl N-[2,3-dichloro-4-[2-[[(1S, 2R)-2-hydroxy-2-(4-hydroxy-phenyl)-1-methylethyl]amino]ethyl]phenyl]aminoacetate 
• 227467-83-6 ethyl N-[2,5-dichloro-4-[2-[[(1S, 2R)-2-hydroxy-2-(4-hydroxy-phenyl)-1-methylethyl]amino]ethyl]phenyl]aminoacetate 
• 1028271-87-5 (3-Chloro-4-{2-[(1S,2R)-2-hydroxy-2-(4-hydroxy-phenyl)-1-methyl-ethylamino]-ethyl}-phenylamino)-acetic acid ethyl ester 
• 227467-69-8 ethyl N-[4-(2-bromoethyl)-2,5-dichlorophenyl]aminoacetate 
• 227467-68-7 ethyl N-[4-(2-bromoethyl)-2,3-dichlorophenyl]aminoacetate 

Relevant academic research and scientific papers

Discovery of novel N-phenylglycine derivatives as potent and selective β3-adrenoceptor agonists for the treatment of frequent urination and urinary incontinence

With a novel assay using isolated ferret detrusor to estimate β3-adrenoceptor agonistic activity, we found that a series of glycine derivatives of ritodrine, a β2-adrenoceptor agonist, are potent β3-adrenoceptor agonists,